发明名称 |
RE-DIRECTED IMMUNOTHERAPY |
摘要 |
The invention provides an agent for preventing or treating a condition characterized by the presence of unwanted cells, the agent comprising: (i) a targeting moiety that is capable of targeting to the unwanted cells; and (ii) a T cell antigen, wherein the T cell antigen can be released from the targeting moiety by selective cleavage of a cleavage site in the agent in the vicinity of the unwanted cells. |
申请公布号 |
EP2686020(B1) |
申请公布日期 |
2017.02.22 |
申请号 |
EP20120718715 |
申请日期 |
2012.03.15 |
申请人 |
The University of Birmingham |
发明人 |
COBBOLD, Mark;MILLAR, David |
分类号 |
A61K47/68;A61K39/12;A61K47/65;A61P37/00 |
主分类号 |
A61K47/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|